Atlanta — A new technology containing stem cells and algae material could hold great promise in repairing damaged tissues.
SpherIngenics, based in Atlanta, is developing technology that uses protective capsules — called microbeads — to deliver cell-based therapies to damaged tissue, Nanowerk.com reports. The microbeads are designed to protect cells from the natural inflammatory response, which can cause therapeutic cells to die or travel away from the area in need of repair.
According to Nanowerk.com, each microbead is 200 microns in diameter, contains about 250 stem cells and is made with algae materials.
“When damaged tissue is being repaired by a cell-based therapy, our microbead technology ensures that cells travel to and remain in the targeted area while maintaining continued viability,” SpherIngenics CEO Franklin Bost said. “This technology has the potential to reduce the cost of treatment by eliminating the need for multiple therapeutic procedures.”
The company will move into the next phase of testing to see whether the treatment will also work on damaged cartilage tissue.
Go back to the Cosmetic Surgery Times eNews newsletter.
